Moderna Vaccine Delivered More Risk Than Benefit in Trials for Children 6 to 11, Despite New York Times Positive Spin • Children's Health Defense

Moderna’s COVID-19 vaccine was “found to be safe and effective in inducing immune responses and preventing COVID-19,” according to an analysis of the results of the vaccine trials in children ages 6 to 11, but a closer look reveals the vaccine delivered more risk than benefit.